… Two mAbs (MAb15 and MAb22) induced clearing and neutralizing antibodies in NHPs, but
neutralizing antibodies only in humans. In NHPs, ADAs were more often directed against the …

… Nonetheless, our approach identified a highly potent neutralizing antibody from a patient
sample that had been characterized as having limited antibody response and neutralizing …

… To evaluate the protective efficacy in nonhuman primates, we converted ZGP133/16.3 and
… ) was generated as a control antibody. The neutralizing activities of chimeric MAbs ch133 …

… pertinent to the translation of passive neutralizing antibody transfer as a sustained prevention
strategy in humans. To address this question in a nonhuman primate (NHP) model of HIV-…

… , is unclear in large animals. Intravitreal AAV administration … antibody levels on intravitreal
gene delivery, we quantified the anti-AAV antibodies present in sera from non-human primates …

… neutralizing antibody, LY-CoV555, derived from a convalescent COVID-19 patient. LY-CoV555
was found to have RBD binding and ACE2 blocking … that neutralizing antibodies have …

… in nonhuman primates. We observed that this novel vaccine approach generated protective
levels of immune responses in both mouse and non-human primate … in non-human primates …

… from hard-to-neutralize SHIVBG505 challenge after immunization with native-like BG505
Envelope trimers in nonhuman primates and identify neutralizing antibodies, but not T cell or …

… animals show signs of disease. We assessed the efficacy of a fully human monoclonal antibody,
… of clinical illness in a uniformly lethal nonhuman primate model of NiV disease. Sixteen …

… translated from small to large animals. In contrast to studies … or lumbar cistern) in non-human
primates (NHP). Using either … of circulating anti-AAV-neutralizing antibodies up to a 1:128 …